scholarly article | Q13442814 |
P50 | author | Dieter Hoelzer | Q15437636 |
Nicola Gökbuget | Q47158585 | ||
Monika Brüggemann | Q87941467 | ||
Claudia D Baldus | Q114529739 | ||
P2093 | author name string | Jochen Hecht | |
Helmut Blum | |||
Alexander Graf | |||
Cornelia Schlee | |||
Isabelle Bartram | |||
Martin Neumann | |||
Sandra Heesch | |||
Stefan Schwartz | |||
Stefan Krebs | |||
Stefan K Bohlander | |||
Philipp A Greif | |||
Sebastian Vosberg | |||
P2860 | cites work | The genetic basis of early T-cell precursor acute lymphoblastic leukaemia | Q24601515 |
Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 | ||
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing | Q24612248 | ||
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma | Q24630610 | ||
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. | Q27852046 | ||
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. | Q27852067 | ||
The etiology of Wolf-Hirschhorn syndrome | Q28236976 | ||
Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
PHF6 mutations in T-cell acute lymphoblastic leukemia | Q29394463 | ||
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 | ||
The origin and evolution of mutations in acute myeloid leukemia | Q29614630 | ||
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia | Q29615735 | ||
Frequent pathway mutations of splicing machinery in myelodysplasia | Q29616088 | ||
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study | Q33395926 | ||
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors. | Q33558120 | ||
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia | Q33733461 | ||
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia | Q33788690 | ||
Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia | Q33886181 | ||
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia | Q34131844 | ||
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis | Q34301317 | ||
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. | Q34324645 | ||
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors | Q34566158 | ||
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. | Q34568855 | ||
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993) | Q34612782 | ||
JAK/STAT signaling in hematological malignancies. | Q34641224 | ||
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms | Q34655449 | ||
Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia | Q34670390 | ||
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias | Q34973772 | ||
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia | Q35483684 | ||
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations | Q35723764 | ||
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors | Q36229551 | ||
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia | Q36229601 | ||
Impact of deleterious passenger mutations on cancer progression | Q36637272 | ||
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. | Q37078001 | ||
WT1 mutations in T-ALL | Q37291631 | ||
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. | Q37318226 | ||
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia | Q37369925 | ||
Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. | Q37401075 | ||
Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies | Q37463690 | ||
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness | Q37697850 | ||
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. | Q37812860 | ||
Transcriptional drivers of the T-cell lineage program | Q37977616 | ||
The molecular basis of T cell acute lymphoblastic leukemia | Q38047834 | ||
Early T-cell precursor acute lymphoblastic leukaemia | Q38108514 | ||
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia | Q38287709 | ||
The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia | Q39991646 | ||
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia | Q39999145 | ||
Risk/MRD adapted GMALL trials in adult ALL. | Q40512939 | ||
Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype. | Q40571894 | ||
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia | Q41296537 | ||
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia | Q41911065 | ||
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols | Q42878950 | ||
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). | Q44258484 | ||
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations | Q45860675 | ||
Treatment of adult acute lymphoblastic leukemia | Q46187922 | ||
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. | Q51549649 | ||
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. | Q52933515 | ||
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL | Q56965918 | ||
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) | Q58414406 | ||
MLL2 and KDM6A mutations in patients with Kabuki syndrome | Q59697631 | ||
Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia | Q61774820 | ||
NOTCH mutations as prognostic markers in T-ALL | Q82884569 | ||
High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation | Q84470178 | ||
JAK1 mutations are not frequent events in adult T-ALL: a GRAALL study | Q84572720 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2754-2766 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Mutational spectrum of adult T-ALL | |
P478 | volume | 6 |
Q92195317 | A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing |
Q45646052 | A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia. |
Q38285814 | A genome wide transcriptional model of the complex response to pre-TCR signalling during thymocyte differentiation. |
Q93013059 | Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation |
Q60911648 | CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia |
Q92627035 | Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia |
Q37665574 | Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes |
Q91451295 | Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma |
Q47636038 | E3 ubiquitin ligases in cancer and implications for therapies |
Q37343797 | Epigenetics of hematopoiesis and hematological malignancies |
Q47783708 | Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia |
Q34510463 | Functional and pathological relevance of HERC family proteins: a decade later. |
Q35678548 | Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy |
Q90216134 | Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene |
Q42777609 | Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia. |
Q37662261 | Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations |
Q92856896 | HERCing: Structural and Functional Relevance of the Large HERC Ubiquitin Ligases |
Q33798544 | Identification of a novel functional JAK1 S646P mutation in acute lymphoblastic leukemia |
Q49568203 | Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia |
Q39430735 | In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. |
Q52872966 | Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling. |
Q28394317 | MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance |
Q29147572 | Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B |
Q52593673 | New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. |
Q92816227 | Next-Generation Sequencing in Acute Lymphoblastic Leukemia |
Q92188750 | Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression |
Q37287489 | Novel dynamin 2 mutations in adult T-cell acute lymphoblastic leukemia |
Q35692410 | PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia. |
Q37536445 | Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI |
Q57810481 | Polycomb complexes in normal and malignant hematopoiesis |
Q91559526 | Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors |
Q26864460 | Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine |
Q61447949 | Regulatory network analysis reveals the oncogenesis roles of feed-forward loops and therapeutic target in T-cell acute lymphoblastic leukemia |
Q38906194 | Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer |
Q49910540 | SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia |
Q38744314 | Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL. |
Q54963328 | Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia. |
Q42319064 | Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia |
Q50803287 | Splicing Factor Mutations in Cancer. |
Q37438996 | Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia |
Q90160294 | The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia |
Q39099555 | The genetics and molecular biology of T-ALL. |
Q39170500 | The promise of Janus kinase inhibitors in the treatment of hematological malignancies |
Q89835369 | Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia |
Q42440865 | Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia |
Q91557800 | Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified |
Q92906458 | Zebrafish and Medaka: Two Teleost Models of T-Cell and Thymic Development |
Q52347573 | [Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia]. |
Search more.